1. [A case of invasive intraductal papillary mucinous carcinoma arising from jejunal heterotopic pancreas].
- Author
-
Sawahashi S, Abe Y, Suzuki F, Nabeshima T, Shoji M, Nakamura T, Nishise Y, Kuroki M, Otake H, and Hirakawa H
- Subjects
- Female, Humans, Jejunum pathology, Middle Aged, Pancreas diagnostic imaging, Pancreas surgery, Pancreatic Neoplasms, Adenocarcinoma surgery, Adenocarcinoma, Mucinous diagnostic imaging, Adenocarcinoma, Mucinous surgery, Adenocarcinoma, Papillary surgery, Carcinoma, Pancreatic Ductal diagnostic imaging, Carcinoma, Pancreatic Ductal pathology, Carcinoma, Pancreatic Ductal surgery, Pancreatic Neoplasms diagnostic imaging, Pancreatic Neoplasms pathology, Pancreatic Neoplasms surgery
- Abstract
Intraductal papillary mucinous carcinoma (IPMC) arising from the heterotopic pancreas is rare. A case of IPMC metastasis from the jejunal heterotopic pancreas was described. The heterotopic pancreas could be the source of the submucosal tumor-like lesion found in the small intestine with an elevated carbohydrate antigen (CA) 19-9 level. A 60-year-old woman was admitted to the hospital with pulmonary thromboembolism and anemia. The level of CA19-9, a tumor marker, was found to be 211.8U/ml. A tumor in the jejunum was discovered using contrast-enhanced computed tomography. There were also a number of hepatic tumors found. A submucosal tumor-like lesion in the jejunum was discovered during an enteroscopy, and a biopsy revealed it to be an adenocarcinoma. Partial resection of the jejunum was performed to control hemorrhage. Histopathology revealed an invasive IPMC arising from a heterotopic pancreas (Heinrich type II) and chemotherapy with gemcitabine and nab-paclitaxel was initiated. There have only been three cases of invasive IPMC from a heterotopic pancreas reported, and this is the first one to include chemotherapeutic treatment of distant metastasis.
- Published
- 2022
- Full Text
- View/download PDF